Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amir R Afshari"'
The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review
Autor:
Negar Shafaei-Bajestani, Amirhossein Sahebkar, Elmira Mohtashami, Amir R Afshari, Seyed Hadi Mousavi, Mohammad Jalili-Nik, Hamid Mollazadeh
Publikováno v:
Current Drug Metabolism. 21:564-578
Glioblastoma multiforme (GBM), as the most lethal brain tumor, continues to be incurable. Considering the high mortality rate of GBM, it is crucial to develop new treatment approaches. Conventional therapies, including maximal surgical resection, rad
Publikováno v:
Journal of Oncology, Vol 2020 (2020)
One of the most lethal forms of CNS pathologies is glioblastoma multiforme (GBM) that represents high invasiveness, uncontrolled proliferation, and angiogenic features. Its invasiveness is responsible for the high recurrence even after maximal surgic
Autor:
Amir R, Afshari, Mehdi, Sanati, Samaneh, Aminyavari, Farzaneh, Shakeri, Bahram, Bibak, Zakieh, Keshavarzi, Mohammad, Soukhtanloo, Mohammad, Jalili-Nik, Mohammad Montazami, Sadeghi, Hamid, Mollazadeh, Thomas P, Johnston, Amirhossein, Sahebkar
Publikováno v:
Critical Reviews in Oncology/Hematology. 172:103625
The most widespread, malignant, and deadliest type of glial tumor is glioblastoma multiforme (GBM). Despite radiation, chemotherapy, and radical surgery, the median survival of afflicted individuals is about 12 months. Unfortunately, existing therape
Autor:
Thomas P. Johnston, Maryam Givari, Mohammad Montazami Sadeghi, Bahram Bibak, Abolfazl Maghrouni, Amirhossein Sahebkar, Hamid Mollazadeh, Amir R Afshari, Mohammad Jalili-Nik
Publikováno v:
International immunopharmacology. 93
Glioblastoma multiforme (GBM), as one of the immunosuppressive and common intrinsic brain tumors in adults, remains an intractable malignancy to manage. Since the standard of care for treatment, which includes surgery and chemoradiation, has not prov
Evidence from preclinical studies suggests that the competitive HMG-CoA reductase (HMGCR) inhibitors universally known as 'statins,' in addition to being powerful drugs that reduce cholesterol and improve cardiovascular risk, also have promising anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5264c1f16a60c1e703f0fb6253fb886